TY - JOUR
T1 - Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel
AU - Oestreich, Julie H.
AU - Holt, John
AU - Dunn, Steven P.
AU - Smyth, Susan S.
AU - Campbell, Charles L.
AU - Charnigo, Richard
AU - Akers, Wendell S.
AU - Steinhubl, Steven R.
PY - 2009/5
Y1 - 2009/5
N2 - BACKGROUND: Variable platelet response to clopidogrel has been widely observed. Studies have shown that the mean aggregation response to clopidogrel can be changed by a higher maintenance dose. However, these studies have not focused on individual changes. OBJECTIVES: This study examined the platelet function effects of increasing the maintenance clopidogrel dose from 75 to 150 mg/day with a focus on inter-individual response. PATIENTS/METHODS: Twenty patients with known coronary artery disease receiving 75 mg/day clopidogrel were recruited and given 150 mg/day clopidogrel for 30 days, then returned to 75 mg/day for an additional 30 days. Platelet function was assessed through light-transmittance aggregometry (LTA) and the VerifyNow P2Y12 assay at baseline, 30 days, and 60 days. RESULTS: Mean platelet inhibition was significantly improved with the increased maintenance dose when measured by the VerifyNow P2Y12 assay (P2Y12 reaction units: 191±15 vs. 158±17, P=0.013), but not when measured by LTA (LTA-adenosine diphosphate 5: 40±3 vs. 36±3, P = 0.11; LTA-adenosine diphosphate 20: 50±3 vs. 47±3, P = 0.23). However, only 50% of individual patients experienced improved platelet inhibition, as measured by the VerifyNow P2Y12 assay, when treated with the increased maintenance dose. Furthermore, poor baseline platelet response did not predict improved responsiveness at the increased dose. CONCLUSION: Despite changing the population's mean antiplatelet response, an increased maintenance dose of clopidogrel did not improve antiplatelet response in a substantial number of patients; nor did baseline platelet function predict response to a higher maintenance dose.
AB - BACKGROUND: Variable platelet response to clopidogrel has been widely observed. Studies have shown that the mean aggregation response to clopidogrel can be changed by a higher maintenance dose. However, these studies have not focused on individual changes. OBJECTIVES: This study examined the platelet function effects of increasing the maintenance clopidogrel dose from 75 to 150 mg/day with a focus on inter-individual response. PATIENTS/METHODS: Twenty patients with known coronary artery disease receiving 75 mg/day clopidogrel were recruited and given 150 mg/day clopidogrel for 30 days, then returned to 75 mg/day for an additional 30 days. Platelet function was assessed through light-transmittance aggregometry (LTA) and the VerifyNow P2Y12 assay at baseline, 30 days, and 60 days. RESULTS: Mean platelet inhibition was significantly improved with the increased maintenance dose when measured by the VerifyNow P2Y12 assay (P2Y12 reaction units: 191±15 vs. 158±17, P=0.013), but not when measured by LTA (LTA-adenosine diphosphate 5: 40±3 vs. 36±3, P = 0.11; LTA-adenosine diphosphate 20: 50±3 vs. 47±3, P = 0.23). However, only 50% of individual patients experienced improved platelet inhibition, as measured by the VerifyNow P2Y12 assay, when treated with the increased maintenance dose. Furthermore, poor baseline platelet response did not predict improved responsiveness at the increased dose. CONCLUSION: Despite changing the population's mean antiplatelet response, an increased maintenance dose of clopidogrel did not improve antiplatelet response in a substantial number of patients; nor did baseline platelet function predict response to a higher maintenance dose.
KW - Adenosine diphosphate
KW - Blood platelets
KW - Clopidogrel
KW - Coronary artery disease
KW - Platelet aggregation
KW - Purinoceptor P2Y12
UR - http://www.scopus.com/inward/record.url?scp=66349118978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66349118978&partnerID=8YFLogxK
U2 - 10.1097/MCA.0b013e328329924b
DO - 10.1097/MCA.0b013e328329924b
M3 - Review article
C2 - 19318928
AN - SCOPUS:66349118978
SN - 0954-6928
VL - 20
SP - 207
EP - 213
JO - Coronary Artery Disease
JF - Coronary Artery Disease
IS - 3
ER -